The average 5-year survival rate for CRC is 60%, a high expression of FLNA and POLR1B represents a significantly lower probability of the survival of CRC patients’, but only FLNA can be considered as a prognostic biomarker with HR = 1.25 and p = 0.025. The gene discussed is POLR1B; the disease is colorectal carcinoma.